721 related articles for article (PubMed ID: 19654482)
21. Chest physicians' knowledge of appropriate thromboprophylaxis: insights from the PROMOTE study.
Bikdeli B; Sharif-Kashani B; Raeissi S; Ehteshami-Afshar S; Behzadnia N; Masjedi MR
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):667-72. PubMed ID: 21986466
[TBL] [Abstract][Full Text] [Related]
22. Thromboprophylaxis during chemotherapy after advanced cancer.
Agnelli G; Verso M
Thromb Res; 2007; 120 Suppl 2():S128-32. PubMed ID: 18023706
[TBL] [Abstract][Full Text] [Related]
23. Thromboprophylaxis during chemotherapy in patients with advanced cancer.
Agnelli G; Verso M
Thromb Res; 2010 Apr; 125 Suppl 2():S17-20. PubMed ID: 20433999
[TBL] [Abstract][Full Text] [Related]
24. Deep vein thrombosis prophylaxis: friend or foe.
Rahman S
Am J Ther; 2009; 16(4):300-3. PubMed ID: 19092638
[TBL] [Abstract][Full Text] [Related]
25. Routine pharmacological venous thromboembolism prophylaxis in frail older hospitalised patients: where is the evidence?
Greig MF; Rochow SB; Crilly MA; Mangoni AA
Age Ageing; 2013 Jul; 42(4):428-34. PubMed ID: 23557678
[TBL] [Abstract][Full Text] [Related]
26. Cancer patients and awareness of venous thromboembolism.
Sousou T; Khorana AA
Cancer Invest; 2010 Jan; 28(1):44-5. PubMed ID: 20001296
[TBL] [Abstract][Full Text] [Related]
27. Venous thromboembolism prophylaxis for the general surgical patient: where do we stand?
Petralia GA; Kakkar AK
Semin Respir Crit Care Med; 2008 Feb; 29(1):83-9. PubMed ID: 18302090
[TBL] [Abstract][Full Text] [Related]
28. Primary venous thromboembolism prophylaxis in ambulatory cancer patients.
Aikens GB; Rivey MP; Hansen CJ
Ann Pharmacother; 2013 Feb; 47(2):198-209. PubMed ID: 23386067
[TBL] [Abstract][Full Text] [Related]
29. Risk stratification and venous thromboprophylaxis in hospitalized medical and cancer patients.
Prandoni P; Samama MM
Br J Haematol; 2008 May; 141(5):587-97. PubMed ID: 18422787
[TBL] [Abstract][Full Text] [Related]
30. The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized cancer patients.
Khorana AA
Oncologist; 2007 Nov; 12(11):1361-70. PubMed ID: 18055857
[TBL] [Abstract][Full Text] [Related]
31. The National Comprehensive Cancer Center Network (NCCN) guidelines on the management of venous thromboembolism in cancer patients.
Streiff MB;
Thromb Res; 2010 Apr; 125 Suppl 2():S128-33. PubMed ID: 20433992
[No Abstract] [Full Text] [Related]
32. Diagnosis and initial treatment of venous thromboembolism in patients with cancer.
Streiff MB
J Clin Oncol; 2009 Oct; 27(29):4889-94. PubMed ID: 19738109
[TBL] [Abstract][Full Text] [Related]
33. The incidence and risk of venous thromboembolism associated with cancer and nonsurgical cancer treatment.
Falanga A
Cancer Invest; 2009 Jan; 27(1):105-15. PubMed ID: 19160098
[TBL] [Abstract][Full Text] [Related]
34. Low-molecular-weight heparin for thromboprophylaxis.
Camporese G; Bernardi E
Curr Opin Pulm Med; 2009 Sep; 15(5):443-54. PubMed ID: 19593139
[TBL] [Abstract][Full Text] [Related]
35. Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practice.
Soto-Cárdenas MJ; Pelayo-García G; Rodríguez-Camacho A; Segura-Fernández E; Mogollo-Galván A; Giron-Gonzalez JA
Palliat Med; 2008 Dec; 22(8):965-8. PubMed ID: 18952751
[TBL] [Abstract][Full Text] [Related]
36. Role of anticoagulation in the management of pancreatic cancer.
Sohail MA; Saif MW
JOP; 2009 Mar; 10(2):82-7. PubMed ID: 19287098
[TBL] [Abstract][Full Text] [Related]
37. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update.
Lyman GH; Bohlke K; Falanga A;
J Oncol Pract; 2015 May; 11(3):e442-4. PubMed ID: 25873061
[No Abstract] [Full Text] [Related]
38. Thromboprophylaxis in trauma: a review of methods, evidence and guidelines.
Vaughan-Shaw PG; Pavlou P; Manjaly JG; Ward P
Acta Orthop Belg; 2011 Feb; 77(1):1-8. PubMed ID: 21473437
[TBL] [Abstract][Full Text] [Related]
39. A review of the practical advantages of low molecular weight heparin in the treatment of cancer-related venous thromboembolism.
Rhodes S; Bond S
Eur J Oncol Nurs; 2008 Dec; 12(5):425-9. PubMed ID: 18842458
[TBL] [Abstract][Full Text] [Related]
40. Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action.
Khorana AA; Streiff MB; Farge D; Mandala M; Debourdeau P; Cajfinger F; Marty M; Falanga A; Lyman GH
J Clin Oncol; 2009 Oct; 27(29):4919-26. PubMed ID: 19720907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
